Becton, Dickinson and Company
HealthcareNYSE:BDX · New York Stock Exchange
-$1.57 today
Vol 1.08M · Avg 2.79M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$21.4B of revenue converted into $1.1B of net income for the selected period. Gross margin is 46.4% and net margin is 4.9%, showing how much revenue survives after costs and taxes. EPS is $3.95, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.8B +8.2% | $20.2B +4.2% | $19.4B +2.7% | $18.9B -1.4% | $19.1B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $11.9B +7.8% | $11.1B -1.3% | $11.2B +7.8% | $10.4B -1.0% | $10.5B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $9.9B +8.8% | $9.1B +11.7% | $8.2B -3.6% | $8.5B -1.8% | $8.6B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 45.4% +0.2pp | 45.2% +3.0pp | 42.2% -2.7pp | 44.9% -0.2pp | 45.1% | 9.8% | 28.9% | 38.3% |
| Research & Development | $1.3B +6.2% | $1.2B -3.8% | $1.2B -1.5% | $1.3B -1.8% | $1.3B | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $5.3B +8.6% | $4.9B +2.9% | $4.7B +0.2% | $4.7B -0.2% | $4.7B | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $7.3B +9.2% | $6.7B +11.0% | $6.1B -2.2% | $6.2B -2.9% | $6.4B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $2.5B +7.7% | $2.3B -0.1% | $2.3B +2.6% | $2.2B -0.0% | $2.2B | $374.2M | $1.2B | $631.8M |
| EBITDA | $5.0B +2.9% | $4.8B +9.5% | $4.4B -0.2% | $4.4B +0.4% | $4.4B | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 22.7% -1.2pp | 23.9% +1.2pp | 22.7% -0.6pp | 23.4% +0.4pp | 23.0% | 5.6% | 46.3% | 42.0% |
| Operating Income | $2.6B +7.6% | $2.4B +13.5% | $2.1B -7.5% | $2.3B +1.4% | $2.3B | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 11.8% -0.1pp | 11.9% +1.0pp | 10.9% -1.2pp | 12.1% +0.3pp | 11.8% | 16.6% | 24.1% | 22.0% |
| Interest Income | $38.0M -76.7% | $163.0M +232.7% | $49.0M +206.3% | $16.0M +77.8% | $9.0M | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $613.0M +16.1% | $528.0M +16.8% | $452.0M +13.6% | $398.0M -15.1% | $469.0M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$696.0M -77.6% | -$392.0M +12.7% | -$449.0M +10.0% | -$499.0M +10.6% | -$558.0M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $1.9B -6.1% | $2.0B +20.6% | $1.7B -6.8% | $1.8B +5.4% | $1.7B | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 8.6% -1.3pp | 9.9% +1.4pp | 8.6% -0.9pp | 9.4% +0.6pp | 8.8% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $204.0M -32.0% | $300.0M +127.3% | $132.0M -10.8% | $148.0M +68.2% | $88.0M | $1.3B | -$1.6B | $745.2M |
| Net Income | $1.7B -1.6% | $1.7B +14.9% | $1.5B -16.6% | $1.8B -15.0% | $2.1B | $4.9B | $4.8B | $4.7B |
| Net Margin | 7.7% -0.8pp | 8.4% +0.8pp | 7.7% -1.8pp | 9.4% -1.5pp | 10.9% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $6 -0.7% | $6 +18.3% | $5 -16.2% | $6 -14.3% | $7 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $6 -0.5% | $6 +18.6% | $5 -16.0% | $6 -14.2% | $7 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $286.6M -1.1% | $289.8M +1.2% | $286.3M +0.4% | $285.0M -1.5% | $289.3M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $287.1M -1.3% | $291.0M +0.9% | $288.4M +0.4% | $287.4M -1.6% | $292.1M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
argenx SE
NASDAQ:ARGX
$55.62B
Cardinal Health, Inc.
NYSE:CAH
$52.45B
Edwards Lifesciences Corporation
NYSE:EW
$48.86B
IDEXX Laboratories, Inc.
NASDAQ:IDXX
$44.11B
Haleon plc
NYSE:HLN
$40.28B
Agilent Technologies, Inc.
NYSE:A
$36.57B
Alcon Inc.
NYSE:ALC
$32.51B
IQVIA Holdings Inc.
NYSE:IQV
$29.85B
ResMed Inc.
NYSE:RMD
$28.05B
Veeva Systems Inc.
NYSE:VEEV
$25.79B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does BDX generate?
Becton, Dickinson and Company (BDX) reported $21.84B of revenue in fiscal 2025.
Is BDX profitable?
Becton, Dickinson and Company (BDX) reported $1.68B of net income, with a net margin of 7.7%.
Explore More
Continue the stock analysis
Jump to another research area for this company.